BACKGROUND Chemotherapy-induced thrombocytopenia (CIT) is an important cause of morbitity in patients with cancer. AIM To investigate the effect of the baseline plasma D-dimer level, an important marker for thrombotic activity, on chemotherapy-induced thrombocytopenia in patients with stage III colon cancer. MATERIALS AND METHODS A total of 43 (28 men) eligible patients were divided into tw...